The Healthline report on the JAMA Network Open analysis of Nurses’ Health Study II data correctly highlights that plant-forward patterns correlate with less weight gain across the menopausal transition, yet it underplays the study’s observational design. This 12-year follow-up of 38,000 women relied on repeated food-frequency questionnaires and self-reported weights rather than randomized assignment or objective measures, leaving room for residual confounding by unmeasured lifestyle factors. The standout result—lowest obesity incidence among adherents to the Planetary Health Diet and low Empirical Dietary Index for Hyperinsulinemia (EDIH) patterns—points to reduced insulin excursions from lower red-meat and ultra-processed-food intake as a plausible mechanism, consistent with earlier cohort findings in the Women’s Health Initiative (n=48,835) showing similar insulin-mediated weight trends. A 2022 meta-analysis in Menopause (15 RCTs, 1,872 participants) further supports that Mediterranean-style interventions improve body composition post-menopause, though effect sizes shrink when trials control for concurrent exercise. What the original coverage missed is the potential interaction with hormone-therapy status: stratified NHS II data suggest the dietary benefit is attenuated among current users, implying diet may partly substitute for lost estrogen effects on insulin sensitivity. Clinicians should therefore view these patterns as adjunctive, not standalone, and monitor for B12 and iron shortfalls that can emerge in long-term plant-heavy shifts.